Approval · Notice of Compliance 9355 · 2008
KEPPRA: Notice of Compliance 9355
Issued February 5, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9355
- Date
- February 5, 2008
- Company
- Ucb IncSmyrna, Georgia, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the actions and clinical pharmacology section of the product monograph
- Therapeutic class
- Antiepileptic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KEPPRA | Not yet assigned | — |
Medicinal ingredients
- LEVETIRACETAM 500 MG per TAB
- LEVETIRACETAM 750 MG per TAB
- LEVETIRACETAM 250 MG per TAB